Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from buy to ...
Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...
Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results